Shanxi Qianyecao Biotech QYC
Ipamorelin
Finnrick tested 4 samples of Ipamorelin (GHS agonist) from Shanxi Qianyecao Biotech QYC between 25 Nov 2025 and 6 May 2026. Test scores average over 7, no score below 6, and at least 2 tests warrant a tentative Finnrick Rating of A (Great).
Finnrick Rating™
Tentative Rating
Shanxi Qianyecao Biotech QYC
Ipamorelin
Tested 4 Samples
Last test 6 May 2026
Take Action
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Ipamorelin tests from top-rated vendors:
All Ipamorelin tests from Shanxi Qianyecao Biotech QYC
Samples are tested in commercial labs
Tests Count
4
Scores
AVGMINMAX
Last
6 May 2026
First
25 Nov 2025
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 6 May 2026 | View | 10mg | 10.4mg | +4.0% | 99.90% | 045 | White Label / Silver Crimp / White Cap | Lab E | Public | |
| 28 Apr 2026 | View | 5mg | 4.96mg | -0.8% | 99.40% | 1/12/26 | No Label / Silver Crimp / Black Cap | Lab E | Public | |
| 10 Feb 2026 | View | 5mg | 5.2mg | +4.0% | 99.70% | (no batch ID) | White Label / Silver Crimp / White Cap | Lab G | Public | |
| 25 Nov 2025 | View | 5mg | 5.17mg | +3.4% | 99.45% | 10/27/25 | White Label / Silver Crimp / White Cap | Lab E | Public | |